| Literature DB >> 28145603 |
K Dern1, M Watts1, B Werle1, A van Eps2, C Pollitt2, J Belknap1.
Abstract
BACKGROUND: In the oligofructose (OF) model of sepsis-related laminitis (SRL), digital hypothermia ("cryotherapy") initiated before the onset of clinical signs is reported not only to limit lamellar injury, but also to cause marked inhibition of lamellar inflammatory signaling. HYPOTHESIS/Entities:
Keywords: Cryotherapy; Equine; Inflammation
Mesh:
Substances:
Year: 2017 PMID: 28145603 PMCID: PMC5354059 DOI: 10.1111/jvim.14633
Source DB: PubMed Journal: J Vet Intern Med ISSN: 0891-6640 Impact factor: 3.333
Lamellar tissue inflammatory mediator copy number expression data: Forelimbs which were treated with hypothermia (CRYO) compared with untreated (NON‐CRYO) limbs
| Inflammatory Mediator | NON‐CRYO | CRYO |
|---|---|---|
| E‐selectin | ||
| Fold increase/NON‐RX | 3.47 | |
| Copy number | 1.70 × 104 (7.90 × 103–3.53 × 104) | 5.90 × 104 (3.45 × 104–1.03 × 105) |
| ICAM‐1 | ||
| Fold increase/NON‐RX | 28.25 | |
| Copy number | 1.01 × 104 (5.00 × 103–1.53 × 104) | 2.85 × 105 (3.38 × 104–7.04 × 105) |
| CXCL‐1 | ||
| Fold increase/NON‐RX | 1.50 | |
| Copy number | 3.15 × 104 (8.91 × 103–1.10 × 105) | 4.74 × 104 (2.37 × 104–9.55 × 104) |
| CXCL‐8 (IL‐8) | ||
| Fold increase/NON‐RX | 0.51 | |
| Copy number | 1.70 × 104(3.96 × 103–8.96 × 104) | 8.92 × 103 (2.71 × 103–1.42 × 104) |
| IL‐6 | ||
| Fold increase/NON‐RX | 0.37 | |
| Copy number | 3.22 × 104 (7.02 × 103–8.70 × 104) | 1.17 × 104 (9.55 × 102–14.7 × 104) |
| IL‐1β | ||
| Fold increase/NON‐RX | 0.49 | |
| Copy number | 5.86 × 104 (1.62 × 104–1.20 × 105) | 2.88 × 104 (1.28 × 104–1.09 × 105) |
| CXCL‐6 | ||
| Fold increase/NON‐RX | 0.88 | |
| Copy number | 7.79 × 103 (4.52 × 103–2.61 × 104) | 6.83 × 103 (2.22 × 103–1.51 × 104) |
| IL‐10 | ||
| Fold increase/NON‐RX | 0.96 | |
| Copy number | 7.79 × 102 (2.89 × 102–1.20 × 103) | 7.49 × 102 (4.79 × 102–1.61 × 103) |
| MCP‐1 | ||
| Fold increase/NON‐RX | 2.79 | |
| Copy number | 4.32 × 103 (1.62 × 103–6.45 × 103) | 1.20 × 104 (2.33 × 103–2.70 × 104) |
| MCP‐2 | ||
| Fold increase/NON‐RX | 1.47 | |
| Copy number | 1.56 × 105 (1.00 × 105–3.48 × 105) | 2.35 × 105 (1.46 × 105–5.45 × 105) |
| COX‐2 | ||
| Fold increase/NON‐RX | 0.17 | |
| Copy number | 2.30 × 104 (4.58 × 103–6.75 × 104) | 3.90 × 104 (1.41 × 103–3.12 × 104) |
ICAM‐1, intracellular adhesion molecule‐1.
The copy number data are expressed as cDNA copies per normalization factor (interquartile range) in both CRYO and NON‐CRYO columns; median fold increase of CRYO copy number (compared to NON‐CRYO) is also presented (top number for each mediator) in the CRYO column.
↑ denotes a statistically significant increase in fold change when compared to the untreated limb.
Statistical correlation of lamellar mRNA concentrations of specific mediators with the histological scores (from previous publication) of both hypothermic (CRYO) and untreated (NON‐CRYO) limbs
| Inflammatory Mediator | CRYO | NON‐CRYO |
|---|---|---|
| E‐selectin | ||
| Spearman/Pearson | −0.43 | −0.10 |
|
| ns | ns |
| ICAM‐1 | ||
| Spearman/Pearson | −0.75 | 0.44 |
|
| .04 | ns |
| CXCL‐1 | ||
| Spearman/Pearson | −0.58 | 0.57 |
|
| ns | ns |
| CXCL‐8 (IL‐8) | ||
| Spearman/Pearson | −0.70 | 0.75 |
|
| ns | .04 |
| IL‐6 | ||
| Spearman/Pearson | −0.68 | 0.45 |
|
| ns | ns |
| IL‐1ß | ||
| Spearman/Pearson | −0.80 | 0.91 |
|
| .02 | .002 |
| CXCL‐6 | ||
| Spearman/Pearson | −0.36 | 0.86 |
|
| ns | .01 |
| IL‐10 | ||
| Spearman/Pearson | −0.60 | 0.54 |
|
| ns | ns |
| MCP‐1 | ||
| Spearman/Pearson | −0.73 | 0.49 |
|
| .04 | ns |
| MCP‐2 | ||
| Spearman/Pearson | −0.55 | 0.48 |
|
| ns | ns |
| COX‐2 | ||
| Spearman/Pearson | −0.44 | −0.44 |
|
| ns | .002 |
ICAM‐1, intracellular adhesion molecule‐1; Ns indicates that the value was not statistically significant.
Denotes a statistically significant correlation between the lamellar mRNA concentrations and histologic score of the lamina. A negative value indicates an inverse correlation.
Figure 1Lamellar mRNA concentrations of inflammatory molecules: Archived nonseptic controls (CON; n = 6) vs OG3 (harvested 36 hours after the onset of lameness; n = 8) vs OG1 (untreated harvested at the onset of OG1 lameness; n = 7). The copy number data are expressed as cDNA copies per normalization factor (interquartile range), median fold increase over CON. *Denotes significant difference between OG1 and CON (P < .05); ^Denotes significant difference between OG3 and CON.